BICLUSTER_ID : UPREG-80
PATHOGENS /2/ : escherichia coli,ehrlichia chaffeensis
TARGETS /30/ : PLA2G4A, ANXA3, CD44, CCL2, CD40, TNFRSF1B, HCK, VCAM1, IL3RA, CYP1B1, AMPD3, CCL5, SAT1, GZMB, STAT1, SELP, ABCC1, CCL8, TAP1, ITGB2, IL2RG, IL1B, SELE, CASP1, ICAM1, PTGER2, TLR2, IL1R1, TNF, PLAUR
Gene SetLeading Edge Genes
NETPATH IL 2 PATHWAY UPPFKFB3, IL18RAP, NMI, RGS16, PMAIP1, IFI44, B4GALT5, SP100, TNFSF10, GADD45G, IL10, PTP4A1, SRC, LCP2, FASLG, IL1B, ICAM1, CASP1, UPP1, SOCS2, IL1R1, GBP1, TNFRSF1B, SOCS3, NOS1AP, GZMB, IER3, CCL4, STK17B, STAT1, KLF6, VIM, IL2RG, FAS, PBEF1, PTGER2, PLAUR, TNF, MX1
NETPATH IL 5 PATHWAY UPIRF2, PLSCR1, CCL2, NFKBIE, CD44, IL3RA, RELB, IER3, MYD88, CASP4, BIRC3, SELP, HLX1, IL1A, LCP2, IL1B, SELE, ICAM1, UPP1, PRDM1
NETPATH IL 4 PATHWAY UPFKBP5, CCL2, SOCS3, CYP1B1, VCAM1, IL1RN, TFEC, GZMB, STK17B, PSCD1, CEBPB, RASGRP1, IL10, IL10RA, DMD, SELE, PTGER2, UPP1
NETPATH IL 1 PATHWAY UPANXA3, MMP14, CCL2, NFKBIE, NFKBIA, AMPD3, MT2A, CXCL2, CCL4, BIRC3, CXCL1, CCL8, IL1A, IL1B, ICAM1, PBEF1
NETPATH KIT RECEPTOR PATHWAY UPPLA2G4A, MCL1, CCL2, TAP1, IL2RG, CCL17, CCL5, KITLG, TNF, IER3
NCI IL12 2PATHWAYSTAT1, GADD45B, IL18RAP, GADD45G, IL2RG, IL1B, IL1R1, CCL4, GZMB
NETPATH IL 4 PATHWAY DOWNSTAT1, KCNN2, GADD45B, VIM, CCL2, TNFSF10, GBP2, NFKBIA, GEM, ICAM1, CXCL2, TLR2, TNF, MX1
NCI AMB2 NEUTROPHILS PATHWAYSRC, SELP, CTGF, ICAM1, HCK, PLAUR, TNF
SA MMP CYTOKINE CONNECTIONCSF1, IL1B, CD44, SELL, TNFRSF1B, TNF
NETPATH IL 3 PATHWAY UPCSF1, MCL1, CCL2, SOCS3, IL3RA, IL1B, SOCS2, CCL4, TNF
NETPATH IL 6 PATHWAY UPGADD45B, MCL1, CD44, MAP3K8, SLC39A14, NMI, SOCS3, TNFRSF11B, STAT1, ABCC1, CXCL1, CADPS, CEBPB, JUNB, POU2F2, MAFF, IRF1, PRDM1, TNF, MX1
NETPATH IL 7 PATHWAY UPCXCL1, MCL1, CCL8, CD44, FAS, CCL19, CCL5, CXCL2, CCL4
NCI IL23PATHWAYSOCS3, STAT1, NFKBIA, IL1B, CXCL1, CCL2, IL18RAP, CXCL9
NCI IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELLIFITM1, VCAM1, SELL, CD40, ITGB2
NETPATH IL 9 PATHWAY UPSOCS3, CCL2, SELL, SOCS2, GZMB
GERY CEBP TARGETSGADD45B, CXCL1, GADD45G, RGS16, SAT1, BTG2, DUSP1, PLAUR
NCI IL6 7PATHWAYSOCS3, STAT1, CEBPD, MCL1, CEBPB, HCK
NCI IL1PATHWAYIL1RN, IL1B, IL1R1, IL1A, MYD88
NCI IL27PATHWAYSTAT1, IL1B, EBI3
NCI VWF INTERACTION WITH COLLAGEN
GRAHAM NORMAL QUIESCENT VS NORMAL DIVIDING UP
RASHI RESPONSE TO IONIZING RADIATION 6
WEINMANN ADAPTATION TO HYPOXIA DN
LINDGREN BLADDER CANCER CLUSTER 2B
KEGG GRAFT VERSUS HOST DISEASE
VARELA ZMPSTE24 TARGETS UP
LINDSTEDT DENDRITIC CELL MATURATION B
BIOCARTA IL1R PATHWAY
KRASNOSELSKAYA ILF3 TARGETS UP
RASHI RESPONSE TO IONIZING RADIATION 2
RADAEVA RESPONSE TO IFNA1 UP
AMIT EGF RESPONSE 40 HELA
BOWIE RESPONSE TO EXTRACELLULAR MATRIX
CORUM MCL1-NOXA COMPLEX
JEON SMAD6 TARGETS UP
MITSIADES RESPONSE TO APLIDIN UP
THEILGAARD NEUTROPHIL AT SKIN WOUND UP
NCI DISSOLUTION OF FIBRIN CLOT
YAMANAKA GLIOBLASTOMA SURVIVAL UP
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION ERYTHROCYTE UP
CONRAD GERMLINE STEM CELL
LENAOUR DENDRITIC CELL MATURATION DN
KUMAR TARGETS OF MLL AF9 FUSION
HINATA NFKB TARGETS KERATINOCYTE UP
MILICIC FAMILIAL ADENOMATOUS POLYPOSIS DN
MARKEY RB1 ACUTE LOF UP
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 6HR UP
XU AKT1 TARGETS 6HR
HUANG FOXA2 TARGETS UP
POOLA INVASIVE BREAST CANCER UP
WOTTON RUNX TARGETS UP
LIU VAV3 PROSTATE CARCINOGENESIS UP
REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES
SEITZ NEOPLASTIC TRANSFORMATION BY 8P DELETION UP
DAUER STAT3 TARGETS DN
RUTELLA RESPONSE TO HGF VS CSF2RB AND IL4 DN
AMIT EGF RESPONSE 120 HELA
DEBOSSCHER NFKB TARGETS REPRESSED BY GLUCOCORTICOIDS
DANG REGULATED BY MYC DN
FULCHER INFLAMMATORY RESPONSE LECTIN VS LPS UP
LAU APOPTOSIS CDKN2A DN
MCLACHLAN DENTAL CARIES UP
PODAR RESPONSE TO ADAPHOSTIN UP
HOSHIDA LIVER CANCER SUBCLASS S1
KYNG DNA DAMAGE UP
LEE LIVER CANCER E2F1 UP
NCI VIRAL MRNA TRANSLATIONRPS15A, RPL35, RPS11, RPS25, RPL23A, RPS6, RPS10, RPS21, RPS5, RPS9, RPL13, RPS23, RPL11, RPS19, RPL30, RPS7, RPL39, RPL8, RPS8, RPL13A, RPS27, RPS20, RPS3
REACTOME VIRAL MRNA TRANSLATION
HELLER SILENCED BY METHYLATION UP
NCI EUKARYOTIC TRANSLATION TERMINATIONRPS15A, RPL35, RPS11, RPS25, RPL23A, RPS6, RPS10, RPS14, RPS21, RPS5, RPL22, RPS9, RPL13, RPS23, RPL11, RPS19, RPL30, RPS7, RPL39, RPL8, RPS8, RPL37, RPL13A, RPS27, RPS20, RPS3
NCI PEPTIDE CHAIN ELONGATIONRPS15A, RPL35, RPS11, RPS25, RPL23A, RPS6, RPS10, RPS21, RPS5, RPS9, RPL13, RPS23, RPL11, RPS19, RPL30, RPS7, RPL39, RPL8, RPS8, RPL13A, RPS27, RPS20, RPS3
BOWIE RESPONSE TO TAMOXIFEN
ICHIBA GRAFT VERSUS HOST DISEASE 35D UP
SMID BREAST CANCER LUMINAL B DN
ZHOU INFLAMMATORY RESPONSE LPS UP
WONG ENDMETRIUM CANCER UP
FINAK BREAST CANCER SDPP SIGNATURE
VANTVEER BREAST CANCER ESR1 DN
CORUM ITGAV-ITGB8-MMP14-TGFB1 COMPLEX
REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL
VERHAAK AML WITH NPM1 MUTATED UP
BROCKE APOPTOSIS REVERSED BY IL6
REACTOME G ALPHA I SIGNALLING EVENTS
SPIRA SMOKERS LUNG CANCER UP
TIAN TNF SIGNALING VIA NFKB
KEGG TOLL LIKE RECEPTOR SIGNALING PATHWAY
GOLUB ALL VS AML DN
LEE EARLY T LYMPHOCYTE DN
CHIANG LIVER CANCER SUBCLASS CTNNB1 DN
HINATA NFKB TARGETS FIBROBLAST UP
WONG ENDMETRIUM CANCER DN
CHARAFE BREAST CANCER LUMINAL VS BASAL DN
NCI ATF2 PATHWAY
KEGG PRIMARY IMMUNODEFICIENCY
ZHANG INTERFERON RESPONSE
KEGG ASTHMA
CROONQUIST STROMAL STIMULATION UP
CHIARADONNA NEOPLASTIC TRANSFORMATION CDC25 UP
BOYLAN MULTIPLE MYELOMA D DN
KHETCHOUMIAN TRIM24 TARGETS UP
KIM LRRC3B TARGETS
DACOSTA ERCC3 ALLELE XPCS VS TTD UP
HORIUCHI WTAP TARGETS UP
NCI CMYB PATHWAY
WOO LIVER CANCER RECURRENCE UP
ZHANG ANTIVIRAL RESPONSE TO RIBAVIRIN UP
RUTELLA RESPONSE TO CSF2RB AND IL4 DN
CHIARADONNA NEOPLASTIC TRANSFORMATION KRAS CDC25 DN
BIOCARTA TH1TH2 PATHWAY
KEGG JAK STAT SIGNALING PATHWAY
BUDHU LIVER CANCER METASTASIS DN
TSAI DNAJB4 TARGETS UP
MORI PRE BI LYMPHOCYTE DN
DER IFN BETA RESPONSE UP
CORUM 40S RIBOSOMAL SUBUNIT CYTOPLASMICRPS15A, RPS7, RPS11, RPS25, RPS6, RPS10, RPS8, RPS5, RPS21, RPS27, RPS20, RPS9, RPS3, RPS19
DEBIASI APOPTOSIS BY REOVIRUS INFECTION UP
SEIKE LUNG CANCER POOR SURVIVAL
REACTOME EICOSANOID LIGAND BINDING RECEPTORS
BIOCARTA CYTOKINE PATHWAY
GILDEA METASTASIS
AMIT EGF RESPONSE 20 HELA
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 10D DN
SCHLESINGER METHYLATED DE NOVO IN CANCER
ICHIBA GRAFT VERSUS HOST DISEASE 35D DN
BASSO CD40 SIGNALING UP
MUELLER METHYLATED IN GLIOBLASTOMA
BIOCARTA NTHI PATHWAY
TIAN TNF SIGNALING NOT VIA NFKB
MARZEC IL2 SIGNALING UP
NAGASHIMA NRG1 SIGNALING UP
BIOCARTA BLYMPHOCYTE PATHWAY
BOYLAN MULTIPLE MYELOMA C D DN
ZERBINI RESPONSE TO SULINDAC UP
WANG ESOPHAGUS CANCER VS NORMAL UP
FRIDMAN SENESCENCE UP
MAHADEVAN RESPONSE TO MP470 UP
SMID BREAST CANCER NORMAL LIKE UP
FERRARI RESPONSE TO FENRETINIDE UP
SANA RESPONSE TO IFNG UP
HOEBEKE LYMPHOID STEM CELL DN
BIOCARTA CTL PATHWAY
ZHANG ANTIVIRAL RESPONSE TO RIBAVIRIN DN
KEGG LEISHMANIA INFECTION
CHO NR4A1 TARGETS
BEGUM TARGETS OF PAX3 FOXO1 FUSION AND PAX3
BOYLAN MULTIPLE MYELOMA PCA1 UP
REACTOME PEPTIDE CHAIN ELONGATION
WU HBX TARGETS 1 UP
CHEN HOXA5 TARGETS 9HR UP
SEKI INFLAMMATORY RESPONSE LPS UP
CORUM ITGAV-ITGB3-ADAM23 COMPLEX
GRAHAM CML QUIESCENT VS CML DIVIDING UP
SHIRAISHI PLZF TARGETS UP
PARK TRETINOIN RESPONSE AND PML RARA FUSION
ENGELMANN CANCER PROGENITORS UP
MOSERLE IFNA RESPONSE
FOSTER INFLAMMATORY RESPONSE LPS UP
BIOCARTA ASBCELL PATHWAY
NCI EXOCYTOSIS OF ALPHA GRANULE
RODWELL AGING KIDNEY UP
INGA TP53 TARGETS
PEPPER CHRONIC LYMPHOCYTIC LEUKEMIA UP
KEGG CYTOSOLIC DNA SENSING PATHWAY
BIOCARTA GRANULOCYTES PATHWAY
MORI IMMATURE B LYMPHOCYTE UP
HESS TARGETS OF HOXA9 AND MEIS1 DN
CROONQUIST NRAS SIGNALING UP
BIOCARTA TOLL PATHWAY
IIZUKA RECURRENT LIVER CANCER
OSWALD HEMATOPOIETIC STEM CELL IN COLLAGEN GEL DN
BERTUCCI MEDULLARY VS DUCTAL BREAST CANCER UP
RUTELLA RESPONSE TO HGF UP
HOSHIDA LIVER CANCER LATE RECURRENCE UP
PRAMOONJAGO SOX4 TARGETS UP
PICCALUGA ANGIOIMMUNOBLASTIC LYMPHOMA DN
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 1
VERHAAK AML WITH NPM1 MUTATED DN
BIOCARTA PML PATHWAY
CORUM RICH1/AMOT POLARITY COMPLEX FLAG-RICH1 PRECIPITATED
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 16D UP
HAHTOLA SEZARY SYNDROM DN
REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS
BOYAULT LIVER CANCER SUBCLASS G5 DN
ICHIBA GRAFT VERSUS HOST DISEASE D7 UP
TENEDINI MEGAKARYOCYTE MARKERS
CHEN LVAD SUPPORT OF FAILING HEART UP
CORUM ITGA2B-ITGB3-CD9-GP1B-CD47 COMPLEX
LINDSTEDT DENDRITIC CELL MATURATION A
MORI LARGE PRE BII LYMPHOCYTE DN
REACTOME PLATELET ACTIVATION
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 5
BIOCARTA NKT PATHWAY
BROWNE INTERFERON RESPONSIVE GENES
REACTOME SIGNALING IN IMMUNE SYSTEM
ROETH TERT TARGETS UP
BIOCARTA LAIR PATHWAY
FRIDMAN IMMORTALIZATION DN
KEGG NOD LIKE RECEPTOR SIGNALING PATHWAY
CORUM PLC-GAMMA-2-SLP-76-LYN-GRB2 COMPLEX
OSADA ASCL1 TARGETS DN
NUYTTEN EZH2 TARGETS UP
DUTTA APOPTOSIS VIA NFKB
SMIRNOV CIRCULATING ENDOTHELIOCYTES IN CANCER DN
TSAI RESPONSE TO IONIZING RADIATION
DELYS THYROID CANCER UP
CORUM RIBOSOME CYTOPLASMICRPS15A, RPL35, RPS11, RPS25, RPL23A, RPS6, RPS10, RPS21, RPS5, RPS9, RPL13, RPS23, RPL11, RPS19, RPL30, RPS7, RPL39, RPL8, RPS8, RPL13A, RPS27, RPS20, RPS3
DIRMEIER LMP1 RESPONSE EARLY
AMIT SERUM RESPONSE 240 MCF10A
KEGG INTESTINAL IMMUNE NETWORK FOR IGA PRODUCTION
NCI RIBONUCLEOTIDE SALVAGE
SEMENZA HIF1 TARGETS
MCMURRAY TP53 HRAS COOPERATION RESPONSE UP
BENNETT SYSTEMIC LUPUS ERYTHEMATOSUS
ZHAN V1 LATE DIFFERENTIATION GENES UP
ZHOU INFLAMMATORY RESPONSE LIVE UP
RUTELLA RESPONSE TO HGF VS CSF2RB AND IL4 UP
ONDER CDH1 TARGETS 3 DN
NAKAYAMA SOFT TISSUE TUMORS PCA1 UP
NIELSEN MALIGNAT FIBROUS HISTIOCYTOMA UP
BROWNE HCMV INFECTION 8HR UP
TAVOR CEBPA TARGETS UP
REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN
FOSTER INFLAMMATORY RESPONSE LPS DN
FINETTI BREAST CANCER KINOME GREEN
GAURNIER PSMD4 TARGETS
BIOCARTA FIBRINOLYSIS PATHWAY
FARMER BREAST CANCER CLUSTER 1
GRANDVAUX IFN RESPONSE NOT VIA IRF3
SATO SILENCED BY DEACETYLATION IN PANCREATIC CANCER
PICCALUGA ANGIOIMMUNOBLASTIC LYMPHOMA UP
MARKEY RB1 CHRONIC LOF DN
REACTOME FORMATION OF PLATELET PLUG
REACTOME PLATELET DEGRANULATION
GESERICK TERT TARGETS DN
NOJIMA SFRP2 TARGETS DN
KEGG T CELL RECEPTOR SIGNALING PATHWAY
NCI FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEXRPS15A, RPS7, RPS11, RPS25, RPS6, RPS10, RPS8, RPS5, RPS21, RPS27, RPS20, RPS9, RPS3, RPS19
AMIT SERUM RESPONSE 120 MCF10A
TAVOR CEBPA TARGETS DN
LEE LIVER CANCER MYC E2F1 UP
SESTO RESPONSE TO UV C3
KEGG RIBOSOME
NCI IL2 1PATHWAY
GEISS RESPONSE TO DSRNA UP
GRAHAM CML DIVIDING VS NORMAL QUIESCENT DN
SATO SILENCED BY METHYLATION IN PANCREATIC CANCER 1
CORUM LCK-SLP76-PLC-GAMMA-1-LAT COMPLEX PERVANADATE-ACTIVATED
GRANDVAUX IRF3 TARGETS UP
ZHU CMV ALL UP
ROZANOV MMP14 TARGETS UP
NATSUME RESPONSE TO INTERFERON BETA UP
LEE LIVER CANCER HEPATOBLAST
NAGASHIMA EGF SIGNALING UP
SMID BREAST CANCER RELAPSE IN PLEURA DN
REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE
KEGG TYPE I DIABETES MELLITUS
AMIT EGF RESPONSE 60 MCF10A
KEGG CYTOKINE CYTOKINE RECEPTOR INTERACTION
CHEN HOXA5 TARGETS 6HR UP
OSWALD HEMATOPOIETIC STEM CELL IN COLLAGEN GEL UP
SMIRNOV CIRCULATING ENDOTHELIOCYTES IN CANCER UP
NCI FORMATION OF A POOL OF FREE 40S SUBUNITSRPS15A, RPL35, RPS11, RPS25, RPL23A, RPS6, RPS10, RPS21, RPS5, RPS9, RPL13, RPS23, RPL11, RPS19, RPL30, RPS7, RPL39, RPL8, RPS8, RPL13A, RPS27, RPS20, RPS3
MARTINELLI IMMATURE NEUTROPHIL DN
AUJLA IL22 AND IL17A SIGNALING
REACTOME DOWNSTREAM EVENTS IN GPCR SIGNALING
LEE LIVER CANCER MYC TGFA UP
CORUM ITGAV-ITGB3-COL4A3 COMPLEX
LEE LIVER CANCER DENA UP
HALMOS CEBPA TARGETS UP
WU CELL MIGRATION
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 9
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 10D UP
WALLACE PROSTATE CANCER RACE UP
SAGIV CD24 TARGETS DN
KEGG MAPK SIGNALING PATHWAY
WIELAND UP BY HBV INFECTION
GUTIERREZ WALDENSTROEMS MACROGLOBULINEMIA 1 DN
ST INTERFERON GAMMA PATHWAY
UROSEVIC RESPONSE TO IMIQUIMOD
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 3D UP
HARRIS HYPOXIA
FULCHER INFLAMMATORY RESPONSE LECTIN VS LPS DN
KEGG NATURAL KILLER CELL MEDIATED CYTOTOXICITY
REACTOME HEMOSTASIS
KAN RESPONSE TO ARSENIC TRIOXIDE
NETPATH B CELL RECEPTOR PATHWAY DOWN
XU RESPONSE TO TRETINOIN AND NSC682994 UP
SOUCEK MYC TARGETS
BIOCARTA DC PATHWAY
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 6HR DN
BILBAN B CLL LPL DN
KEGG B CELL RECEPTOR SIGNALING PATHWAY
IZADPANAH STEM CELL ADIPOSE VS BONE UP
CORUM ITGA2B-ITGB3-CD47-SRC COMPLEX
ZHAN MULTIPLE MYELOMA LB DN
KEGG AUTOIMMUNE THYROID DISEASE
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION HSC UP
BILD HRAS ONCOGENIC SIGNATURE
LIANG SILENCED BY METHYLATION 2
DAUER STAT3 TARGETS UP
DER IFN ALPHA RESPONSE UP
LEE LIVER CANCER ACOX1 UP
BERENJENO TRANSFORMED BY RHOA FOREVER DN
ADDYA ERYTHROID DIFFERENTIATION BY HEMIN
DAZARD UV RESPONSE CLUSTER G2
EINAV INTERFERON SIGNATURE IN CANCER
MCLACHLAN DENTAL CARIES DN
KEGG ALLOGRAFT REJECTION
AMIT SERUM RESPONSE 40 MCF10A
MAHADEVAN IMATINIB RESISTANCE DN
BROWNE HCMV INFECTION 4HR UP
WONG ENDOMETRIAL CANCER LATE
ZHANG RESPONSE TO IKK INHIBITOR AND TNF UP
ZHU CMV 8 HR UP
BIOCARTA INFLAM PATHWAY
SANA TNF SIGNALING UP
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 8D UP
SCHUETZ BREAST CANCER DUCTAL INVASIVE UP
SENESE HDAC1 AND HDAC2 TARGETS UP
REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX
XU HGF TARGETS INDUCED BY AKT1 6HR
ONDER CDH1 TARGETS 2 DN
CASTELLANO NRAS TARGETS UP
HAHTOLA MYCOSIS FUNGOIDES CD4 UP
KEGG HEMATOPOIETIC CELL LINEAGE
SATO SILENCED BY METHYLATION IN PANCREATIC CANCER 2
SENESE HDAC3 TARGETS UP
KEGG CHEMOKINE SIGNALING PATHWAY
BUDHU LIVER CANCER METASTASIS UP
CHARAFE BREAST CANCER LUMINAL VS MESENCHYMAL DN
FUJII YBX1 TARGETS UP
UZONYI RESPONSE TO LEUKOTRIENE AND THROMBIN
XU HGF SIGNALING NOT VIA AKT1 6HR
JISON SICKLE CELL DISEASE UP
BAELDE DIABETIC NEPHROPATHY DN
NCI IL12 STAT4PATHWAYIL18RAP, IRF1
XU HGF SIGNALING NOT VIA AKT1 48HR UP
NETPATH T CELL RECEPTOR PATHWAY UP
REACTOME FORMATION OF A POOL OF FREE 40S SUBUNITS
GRAHAM CML QUIESCENT VS NORMAL DIVIDING UP
BOHN PRIMARY IMMUNODEFICIENCY SYNDROM DN
GOUYER TATI TARGETS UP
ZHAN MULTIPLE MYELOMA HP UP
NETPATH IL 4 PATHWAY
ZUCCHI METASTASIS DN
LU IL4 SIGNALING
DEURIG T CELL PROLYMPHOCYTIC LEUKEMIA DN
HOFFMANN PRE BI TO LARGE PRE BII LYMPHOCYTE DN
WATTEL AUTONOMOUS THYROID ADENOMA DN
FERRANDO T ALL WITH MLL ENL FUSION UP
Color legend
q-value10.20.050.010.0010.0001
Color
TABLE OF Q-VALUES
escherichia coliehrlichia chaffeensis libertyGeneSet Name
0.00000 0.01786NETPATH_IL_2_PATHWAY_UP
0.00001 0.05924NETPATH_IL_5_PATHWAY_UP
0.00129 0.02314NETPATH_IL_4_PATHWAY_UP
0.00000 0.04640NETPATH_IL_1_PATHWAY_UP
0.00023 0.05936NETPATH_KIT_RECEPTOR_PATHWAY_UP
0.00000 0.00032NCI_IL12_2PATHWAY
0.00000 0.00340NETPATH_IL_4_PATHWAY_DOWN
0.00044 0.01327NCI_AMB2_NEUTROPHILS_PATHWAY
0.00133 0.00029SA_MMP_CYTOKINE_CONNECTION
0.00000 0.00030NETPATH_IL_3_PATHWAY_UP
0.00000 0.00150NETPATH_IL_6_PATHWAY_UP
0.00000 0.00005NETPATH_IL_7_PATHWAY_UP
0.00000 0.00440NCI_IL23PATHWAY
0.00964 0.00065NCI_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL
0.00028 0.00207NETPATH_IL_9_PATHWAY_UP
0.01389 0.05794GERY_CEBP_TARGETS
0.00785 0.00014NCI_IL6_7PATHWAY
0.00686 0.08937NCI_IL1PATHWAY
0.00000 0.03237NCI_IL27PATHWAY
0.10123 0.01500NCI_VWF_INTERACTION_WITH_COLLAGEN
0.00000 0.01105GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.01812 0.00001RASHI_RESPONSE_TO_IONIZING_RADIATION_6
0.00000 0.11374WEINMANN_ADAPTATION_TO_HYPOXIA_DN
0.01415 0.00007LINDGREN_BLADDER_CANCER_CLUSTER_2B
0.00002 0.00002KEGG_GRAFT_VERSUS_HOST_DISEASE
0.01038 0.00228VARELA_ZMPSTE24_TARGETS_UP
0.00000 0.02223LINDSTEDT_DENDRITIC_CELL_MATURATION_B
0.00000 0.06455BIOCARTA_IL1R_PATHWAY
0.00000 0.00644KRASNOSELSKAYA_ILF3_TARGETS_UP
0.00000 0.09956RASHI_RESPONSE_TO_IONIZING_RADIATION_2
0.00000 0.00009RADAEVA_RESPONSE_TO_IFNA1_UP
0.00000 0.15480AMIT_EGF_RESPONSE_40_HELA
0.00001 0.00412BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX
0.16645 0.14845CORUM_MCL1-NOXA_COMPLEX
0.00031 0.03458JEON_SMAD6_TARGETS_UP
0.02480 0.14846MITSIADES_RESPONSE_TO_APLIDIN_UP
0.00000 0.01294THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP
0.12964 0.11045NCI_DISSOLUTION_OF_FIBRIN_CLOT
0.17499 0.11880YAMANAKA_GLIOBLASTOMA_SURVIVAL_UP
0.00220 0.06656TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP
0.17103 0.07782CONRAD_GERMLINE_STEM_CELL
0.02437 0.00000LENAOUR_DENDRITIC_CELL_MATURATION_DN
0.06842 0.10012KUMAR_TARGETS_OF_MLL_AF9_FUSION
0.00000 0.00058HINATA_NFKB_TARGETS_KERATINOCYTE_UP
0.02397 0.06439MILICIC_FAMILIAL_ADENOMATOUS_POLYPOSIS_DN
0.00000 0.00000MARKEY_RB1_ACUTE_LOF_UP
0.14890 0.00719TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP
0.00144 0.00156XU_AKT1_TARGETS_6HR
0.00285 0.10032HUANG_FOXA2_TARGETS_UP
0.03522 0.00000POOLA_INVASIVE_BREAST_CANCER_UP
0.02877 0.12764WOTTON_RUNX_TARGETS_UP
0.00647 0.00000LIU_VAV3_PROSTATE_CARCINOGENESIS_UP
0.00000 0.00023REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES
0.00000 0.00181SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP
0.00000 0.00295DAUER_STAT3_TARGETS_DN
0.00143 0.01422RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN
0.00046 0.00639AMIT_EGF_RESPONSE_120_HELA
0.02153 0.16474DEBOSSCHER_NFKB_TARGETS_REPRESSED_BY_GLUCOCORTICOIDS
0.02480 0.18816DANG_REGULATED_BY_MYC_DN
0.00949 0.07034FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP
0.15456 0.19323LAU_APOPTOSIS_CDKN2A_DN
0.00000 0.00000MCLACHLAN_DENTAL_CARIES_UP
0.01026 0.00465PODAR_RESPONSE_TO_ADAPHOSTIN_UP
0.10124 0.00018HOSHIDA_LIVER_CANCER_SUBCLASS_S1
0.03420 0.04573KYNG_DNA_DAMAGE_UP
0.00843 0.00413LEE_LIVER_CANCER_E2F1_UP
0.01461 0.02372NCI_VIRAL_MRNA_TRANSLATION
0.01642 0.02961REACTOME_VIRAL_MRNA_TRANSLATION
0.00002 0.00000HELLER_SILENCED_BY_METHYLATION_UP
0.01385 0.02343NCI_EUKARYOTIC_TRANSLATION_TERMINATION
0.00472 0.03274NCI_PEPTIDE_CHAIN_ELONGATION
0.00000 0.00007BOWIE_RESPONSE_TO_TAMOXIFEN
0.00769 0.00000ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP
0.00006 0.00253SMID_BREAST_CANCER_LUMINAL_B_DN
0.00000 0.03822ZHOU_INFLAMMATORY_RESPONSE_LPS_UP
0.12623 0.13528WONG_ENDMETRIUM_CANCER_UP
0.08992 0.06018FINAK_BREAST_CANCER_SDPP_SIGNATURE
0.00141 0.07784VANTVEER_BREAST_CANCER_ESR1_DN
0.06972 0.11413CORUM_ITGAV-ITGB8-MMP14-TGFB1_COMPLEX
0.00800 0.00001REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL
0.00000 0.00000VERHAAK_AML_WITH_NPM1_MUTATED_UP
0.00002 0.00011BROCKE_APOPTOSIS_REVERSED_BY_IL6
0.01653 0.00648REACTOME_G_ALPHA_I_SIGNALLING_EVENTS
0.15123 0.03806SPIRA_SMOKERS_LUNG_CANCER_UP
0.00000 0.02222TIAN_TNF_SIGNALING_VIA_NFKB
0.00000 0.00866KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.11780 0.02336GOLUB_ALL_VS_AML_DN
0.04462 0.00816LEE_EARLY_T_LYMPHOCYTE_DN
0.00492 0.17601CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN
0.00000 0.00960HINATA_NFKB_TARGETS_FIBROBLAST_UP
0.11057 0.19268WONG_ENDMETRIUM_CANCER_DN
0.00000 0.04577CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN
0.01874 0.18902NCI_ATF2_PATHWAY
0.03091 0.02818KEGG_PRIMARY_IMMUNODEFICIENCY
0.00000 0.00000ZHANG_INTERFERON_RESPONSE
0.01109 0.02389KEGG_ASTHMA
0.00003 0.00903CROONQUIST_STROMAL_STIMULATION_UP
0.05333 0.01517CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP
0.13163 0.00818BOYLAN_MULTIPLE_MYELOMA_D_DN
0.02879 0.00030KHETCHOUMIAN_TRIM24_TARGETS_UP
0.00004 0.00144KIM_LRRC3B_TARGETS
0.00108 0.07388DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP
0.00002 0.01757HORIUCHI_WTAP_TARGETS_UP
0.13033 0.17873NCI_CMYB_PATHWAY
0.01595 0.05653WOO_LIVER_CANCER_RECURRENCE_UP
0.00057 0.04794ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP
0.12734 0.00000RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN
0.00220 0.00580CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN
0.00439 0.01423BIOCARTA_TH1TH2_PATHWAY
0.00009 0.18395KEGG_JAK_STAT_SIGNALING_PATHWAY
0.00126 0.05362BUDHU_LIVER_CANCER_METASTASIS_DN
0.01475 0.00743TSAI_DNAJB4_TARGETS_UP
0.04300 0.00033MORI_PRE_BI_LYMPHOCYTE_DN
0.00000 0.08872DER_IFN_BETA_RESPONSE_UP
0.00618 0.01564CORUM_40S_RIBOSOMAL_SUBUNIT_CYTOPLASMIC
0.00002 0.00766DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP
0.00018 0.01750SEIKE_LUNG_CANCER_POOR_SURVIVAL
0.01541 0.07915REACTOME_EICOSANOID_LIGAND_BINDING_RECEPTORS
0.00002 0.02223BIOCARTA_CYTOKINE_PATHWAY
0.10376 0.08394GILDEA_METASTASIS
0.00089 0.00673AMIT_EGF_RESPONSE_20_HELA
0.10451 0.00734TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN
0.02296 0.17630SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER
0.18061 0.00000ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_DN
0.00000 0.00000BASSO_CD40_SIGNALING_UP
0.19250 0.02943MUELLER_METHYLATED_IN_GLIOBLASTOMA
0.00024 0.01296BIOCARTA_NTHI_PATHWAY
0.00702 0.02313TIAN_TNF_SIGNALING_NOT_VIA_NFKB
0.00002 0.04723MARZEC_IL2_SIGNALING_UP
0.00000 0.00351NAGASHIMA_NRG1_SIGNALING_UP
0.10036 0.00468BIOCARTA_BLYMPHOCYTE_PATHWAY
0.05549 0.00000BOYLAN_MULTIPLE_MYELOMA_C_D_DN
0.02814 0.13115ZERBINI_RESPONSE_TO_SULINDAC_UP
0.00496 0.15201WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP
0.00001 0.08258FRIDMAN_SENESCENCE_UP
0.00000 0.00131MAHADEVAN_RESPONSE_TO_MP470_UP
0.13855 0.00000SMID_BREAST_CANCER_NORMAL_LIKE_UP
0.00016 0.18558FERRARI_RESPONSE_TO_FENRETINIDE_UP
0.00000 0.00245SANA_RESPONSE_TO_IFNG_UP
0.06971 0.15229HOEBEKE_LYMPHOID_STEM_CELL_DN
0.19720 0.00719BIOCARTA_CTL_PATHWAY
0.00000 0.08743ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN
0.00028 0.00000KEGG_LEISHMANIA_INFECTION
0.14879 0.18281CHO_NR4A1_TARGETS
0.19715 0.15604BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_AND_PAX3
0.05581 0.00000BOYLAN_MULTIPLE_MYELOMA_PCA1_UP
0.00626 0.03578REACTOME_PEPTIDE_CHAIN_ELONGATION
0.00099 0.01391WU_HBX_TARGETS_1_UP
0.00050 0.02231CHEN_HOXA5_TARGETS_9HR_UP
0.00000 0.00000SEKI_INFLAMMATORY_RESPONSE_LPS_UP
0.15380 0.19987CORUM_ITGAV-ITGB3-ADAM23_COMPLEX
0.00000 0.00022GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP
0.09916 0.19556SHIRAISHI_PLZF_TARGETS_UP
0.11638 0.00521PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION
0.00403 0.04783ENGELMANN_CANCER_PROGENITORS_UP
0.00000 0.00000MOSERLE_IFNA_RESPONSE
0.00011 0.00000FOSTER_INFLAMMATORY_RESPONSE_LPS_UP
0.00194 0.00506BIOCARTA_ASBCELL_PATHWAY
0.11091 0.00017NCI_EXOCYTOSIS_OF_ALPHA_GRANULE_
0.15541 0.00000RODWELL_AGING_KIDNEY_UP
0.02526 0.01560INGA_TP53_TARGETS
0.00611 0.03685PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP
0.00000 0.05665KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY
0.15379 0.00128BIOCARTA_GRANULOCYTES_PATHWAY
0.08736 0.00000MORI_IMMATURE_B_LYMPHOCYTE_UP
0.08966 0.00000HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN
0.12202 0.00000CROONQUIST_NRAS_SIGNALING_UP
0.05426 0.13805BIOCARTA_TOLL_PATHWAY
0.02641 0.17711IIZUKA_RECURRENT_LIVER_CANCER
0.00000 0.10357OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN
0.00008 0.03067BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP
0.00005 0.06352RUTELLA_RESPONSE_TO_HGF_UP
0.14286 0.00243HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP
0.00005 0.12936PRAMOONJAGO_SOX4_TARGETS_UP
0.02690 0.01248PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN
0.08745 0.01294YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1
0.08165 0.06829VERHAAK_AML_WITH_NPM1_MUTATED_DN
0.01149 0.13171BIOCARTA_PML_PATHWAY
0.04294 0.05545CORUM_RICH1/AMOT_POLARITY_COMPLEX_FLAG-RICH1_PRECIPITATED
0.00009 0.00011TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP
0.00330 0.02392HAHTOLA_SEZARY_SYNDROM_DN
0.00121 0.10026REACTOME_CLASS_A1_RHODOPSIN_LIKE_RECEPTORS
0.00515 0.00069BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN
0.00000 0.00000ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP
0.00011 0.00032TENEDINI_MEGAKARYOCYTE_MARKERS
0.00159 0.02396CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP
0.13016 0.03083CORUM_ITGA2B-ITGB3-CD9-GP1B-CD47_COMPLEX
0.00000 0.00000LINDSTEDT_DENDRITIC_CELL_MATURATION_A
0.19860 0.00000MORI_LARGE_PRE_BII_LYMPHOCYTE_DN
0.16266 0.00552REACTOME_PLATELET_ACTIVATION
0.03327 0.03802YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5
0.00003 0.00035BIOCARTA_NKT_PATHWAY
0.00000 0.00000BROWNE_INTERFERON_RESPONSIVE_GENES
0.13298 0.00032REACTOME_SIGNALING_IN_IMMUNE_SYSTEM
0.00141 0.00140ROETH_TERT_TARGETS_UP
0.05748 0.00723BIOCARTA_LAIR_PATHWAY
0.00651 0.15168FRIDMAN_IMMORTALIZATION_DN
0.00000 0.00966KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.02722 0.05542CORUM_PLC-GAMMA-2-SLP-76-LYN-GRB2_COMPLEX
0.00002 0.00584OSADA_ASCL1_TARGETS_DN
0.00000 0.11368NUYTTEN_EZH2_TARGETS_UP
0.00000 0.00023DUTTA_APOPTOSIS_VIA_NFKB
0.09897 0.16740SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_DN
0.00126 0.05204TSAI_RESPONSE_TO_IONIZING_RADIATION
0.00200 0.02216DELYS_THYROID_CANCER_UP
0.00802 0.01621CORUM_RIBOSOME_CYTOPLASMIC
0.00000 0.00342DIRMEIER_LMP1_RESPONSE_EARLY
0.00128 0.17684AMIT_SERUM_RESPONSE_240_MCF10A
0.00010 0.08853KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION
0.08953 0.11375NCI_RIBONUCLEOTIDE_SALVAGE
0.14703 0.10625SEMENZA_HIF1_TARGETS
0.00084 0.01999MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_UP
0.00000 0.00011BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS
0.00777 0.00283ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP
0.00000 0.05362ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP
0.01985 0.00908RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP
0.00000 0.16184ONDER_CDH1_TARGETS_3_DN
0.04537 0.00000NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP
0.00438 0.04791NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_UP
0.00256 0.13532BROWNE_HCMV_INFECTION_8HR_UP
0.00020 0.04493TAVOR_CEBPA_TARGETS_UP
0.01072 0.02194REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN
0.00000 0.00078FOSTER_INFLAMMATORY_RESPONSE_LPS_DN
0.05690 0.01670FINETTI_BREAST_CANCER_KINOME_GREEN
0.00000 0.00000GAURNIER_PSMD4_TARGETS
0.00489 0.14269BIOCARTA_FIBRINOLYSIS_PATHWAY
0.00000 0.00000FARMER_BREAST_CANCER_CLUSTER_1
0.00002 0.00730GRANDVAUX_IFN_RESPONSE_NOT_VIA_IRF3
0.00071 0.09089SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER
0.10200 0.19454PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP
0.09710 0.00116MARKEY_RB1_CHRONIC_LOF_DN
0.19586 0.00961REACTOME_FORMATION_OF_PLATELET_PLUG
0.08050 0.01260REACTOME_PLATELET_DEGRANULATION
0.00083 0.00164GESERICK_TERT_TARGETS_DN
0.00025 0.04856NOJIMA_SFRP2_TARGETS_DN
0.10958 0.05666KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY
0.01008 0.08602NCI_FORMATION_OF_THE_TERNARY_COMPLEX__AND_SUBSEQUENTLY__THE_43S_COMPLEX
0.00011 0.00533AMIT_SERUM_RESPONSE_120_MCF10A
0.14255 0.13916TAVOR_CEBPA_TARGETS_DN
0.08000 0.00544LEE_LIVER_CANCER_MYC_E2F1_UP
0.00001 0.11456SESTO_RESPONSE_TO_UV_C3
0.11047 0.04577KEGG_RIBOSOME
0.14764 0.18437NCI_IL2_1PATHWAY
0.00000 0.01274GEISS_RESPONSE_TO_DSRNA_UP
0.00000 0.00118GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN
0.00653 0.17607SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1
0.16873 0.11700CORUM_LCK-SLP76-PLC-GAMMA-1-LAT_COMPLEX_PERVANADATE-ACTIVATED
0.00002 0.00053GRANDVAUX_IRF3_TARGETS_UP
0.00000 0.06440ZHU_CMV_ALL_UP
0.02679 0.15176ROZANOV_MMP14_TARGETS_UP
0.06156 0.11926NATSUME_RESPONSE_TO_INTERFERON_BETA_UP
0.00010 0.02333LEE_LIVER_CANCER_HEPATOBLAST
0.00003 0.01422NAGASHIMA_EGF_SIGNALING_UP
0.09662 0.13160SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_DN
0.02074 0.01764REACTOME_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE
0.00002 0.01050KEGG_TYPE_I_DIABETES_MELLITUS
0.00000 0.06686AMIT_EGF_RESPONSE_60_MCF10A
0.00000 0.00077KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION
0.13852 0.13502CHEN_HOXA5_TARGETS_6HR_UP
0.00000 0.09755OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP
0.01400 0.00642SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP
0.00702 0.02218NCI_FORMATION_OF_A_POOL_OF_FREE_40S_SUBUNITS
0.04089 0.09105MARTINELLI_IMMATURE_NEUTROPHIL_DN
0.00129 0.12142AUJLA_IL22_AND_IL17A_SIGNALING
0.04949 0.10486REACTOME_DOWNSTREAM_EVENTS_IN_GPCR_SIGNALING
0.07586 0.02710LEE_LIVER_CANCER_MYC_TGFA_UP
0.17224 0.18815CORUM_ITGAV-ITGB3-COL4A3_COMPLEX
0.10854 0.00857LEE_LIVER_CANCER_DENA_UP
0.00001 0.03077HALMOS_CEBPA_TARGETS_UP
0.00033 0.18457WU_CELL_MIGRATION
0.05591 0.01729YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9
0.00000 0.00209TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP
0.00004 0.00000WALLACE_PROSTATE_CANCER_RACE_UP
0.00010 0.07135SAGIV_CD24_TARGETS_DN
0.19572 0.19862KEGG_MAPK_SIGNALING_PATHWAY
0.00002 0.00000WIELAND_UP_BY_HBV_INFECTION
0.01179 0.03335GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_DN
0.04922 0.03205ST_INTERFERON_GAMMA_PATHWAY
0.00000 0.00027UROSEVIC_RESPONSE_TO_IMIQUIMOD
0.00000 0.00004TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP
0.00034 0.03906HARRIS_HYPOXIA
0.00002 0.00000FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN
0.03651 0.00017KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY
0.18125 0.00797REACTOME_HEMOSTASIS
0.02558 0.19460KAN_RESPONSE_TO_ARSENIC_TRIOXIDE
0.04764 0.01567NETPATH_B_CELL_RECEPTOR_PATHWAY_DOWN
0.00009 0.00430XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP
0.00037 0.00038SOUCEK_MYC_TARGETS
0.00672 0.00817BIOCARTA_DC_PATHWAY
0.05842 0.08988TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN
0.14289 0.00006BILBAN_B_CLL_LPL_DN
0.09546 0.01548KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY
0.00049 0.06495IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP
0.10198 0.05201CORUM_ITGA2B-ITGB3-CD47-SRC_COMPLEX
0.00002 0.00081ZHAN_MULTIPLE_MYELOMA_LB_DN
0.00009 0.08016KEGG_AUTOIMMUNE_THYROID_DISEASE
0.17340 0.09163TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP
0.00000 0.05938BILD_HRAS_ONCOGENIC_SIGNATURE
0.00000 0.00000LIANG_SILENCED_BY_METHYLATION_2
0.00003 0.06350DAUER_STAT3_TARGETS_UP
0.00000 0.09673DER_IFN_ALPHA_RESPONSE_UP
0.13289 0.05856LEE_LIVER_CANCER_ACOX1_UP
0.00016 0.12473BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN
0.08973 0.02827ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN
0.00004 0.05324DAZARD_UV_RESPONSE_CLUSTER_G2
0.00000 0.00290EINAV_INTERFERON_SIGNATURE_IN_CANCER
0.00002 0.00000MCLACHLAN_DENTAL_CARIES_DN
0.00000 0.00019KEGG_ALLOGRAFT_REJECTION
0.00142 0.03677AMIT_SERUM_RESPONSE_40_MCF10A
0.17364 0.00207MAHADEVAN_IMATINIB_RESISTANCE_DN
0.00000 0.07524BROWNE_HCMV_INFECTION_4HR_UP
0.06386 0.13674WONG_ENDOMETRIAL_CANCER_LATE
0.00000 0.00059ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP
0.00000 0.00029ZHU_CMV_8_HR_UP
0.00000 0.02390BIOCARTA_INFLAM_PATHWAY
0.00000 0.00008SANA_TNF_SIGNALING_UP
0.00000 0.00351TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP
0.01672 0.00142SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP
0.00002 0.03587SENESE_HDAC1_AND_HDAC2_TARGETS_UP
0.01227 0.08056REACTOME_FORMATION_OF_THE_TERNARY_COMPLEX_AND_SUBSEQUENTLY_THE_43S_COMPLEX
0.00014 0.02953XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR
0.00002 0.03586ONDER_CDH1_TARGETS_2_DN
0.00040 0.00715CASTELLANO_NRAS_TARGETS_UP
0.00000 0.02652HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP
0.00021 0.00000KEGG_HEMATOPOIETIC_CELL_LINEAGE
0.03679 0.09153SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2
0.00076 0.17909SENESE_HDAC3_TARGETS_UP
0.00217 0.00209KEGG_CHEMOKINE_SIGNALING_PATHWAY
0.00702 0.16722BUDHU_LIVER_CANCER_METASTASIS_UP
0.00371 0.15226CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN
0.02740 0.03642FUJII_YBX1_TARGETS_UP
0.00044 0.10221UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN
0.00132 0.09161XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR
0.00023 0.00099JISON_SICKLE_CELL_DISEASE_UP
0.06303 0.12445BAELDE_DIABETIC_NEPHROPATHY_DN
0.01630 0.00901NCI_IL12_STAT4PATHWAY
0.05998 0.07602XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP
0.00743 0.15930NETPATH_T_CELL_RECEPTOR_PATHWAY_UP
0.01101 0.02849REACTOME_FORMATION_OF_A_POOL_OF_FREE_40S_SUBUNITS
0.00000 0.00033GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.03648 0.01657BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN
0.03224 0.06698GOUYER_TATI_TARGETS_UP
0.02203 0.05935ZHAN_MULTIPLE_MYELOMA_HP_UP
0.16252 0.02219NETPATH_IL_4_PATHWAY
0.00000 0.05374ZUCCHI_METASTASIS_DN
0.00649 0.00508LU_IL4_SIGNALING
0.01811 0.00554DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN
0.04160 0.00837HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN
0.02507 0.07019WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN
0.07582 0.10014FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP